SCHEMBL19413809

SCHEMBL19413809

Bc1nc(N)c2c(-c3ccc(Oc4ccccc4)cc3)nn([C@@H]3CCCN(C(=O)C=C)C3)c2n1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 17/20 0.77
▸ EGFR P00533 6/20 0.77
▸ TEC P42680 3/20 0.77
▸ BMX P51813 3/20 0.77
▸ TXK P42681 2/20 0.77
▸ LYN P07948 2/20 0.77
▸ FGFR2 P21802 2/20 0.77
▸ ITK Q08881 2/20 0.77
▸ CYP3A4 P08684 2/20 0.77
▸ CYP2C9 P11712 2/20 0.77
▸ CYP2C19 P33261 2/20 0.77
▸ KCNH2 Q12809 2/20 0.77
▸ NUDT5 Q9UKK9 2/20 0.77
▸ RIPK2 O43353 1/20 0.77
▸ NR1I2 O75469 1/20 0.77
▸ SLC22A3 O75751 1/20 0.77
▸ LATS1 O95835 1/20 0.77
▸ NUDT14 O95848 1/20 0.77
▸ ABL1 P00519 1/20 0.77
▸ ERBB2 P04626 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ibrutinib SCHEMBL201642 0.87 BTK (1.00) BTKEGFRTECBMXTXK
Ibrutinib SCHEMBL201641 0.87 BTK (1.00) BTKEGFRTECBMXTXK
Ibrutinib SCHEMBL201859 0.87 BTK (1.00) BTKEGFRTECBMXTXK
Ibrutinib SCHEMBL2244865 0.87 BTK (1.00) BTKEGFRTECBMXTXK
Ibrutinib SCHEMBL2244870 0.87 BTK (1.00) BTKEGFRTECBMXTXK
Ibrutinib SCHEMBL16931737 0.86 BTK (0.85) BTKEGFRTECBMXTXK
SCHEMBL1613626 0.85 EGFR (0.71) BTKEGFRTECBMXTXK
SCHEMBL22625507 0.85 BTK (0.85) BTKEGFRTECBMXTXK
SCHEMBL22625456 0.85 BTK (0.69) BTKEGFRTECBMXTXK
SCHEMBL21428758 0.85 BTK (0.95) BTKEGFRTECBMXTXK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9777009-B2 Deuterated ibrutinib CONCERT PHARMACEUTICALS, INC. (US) 2017-10-03 — — US disclosed
Send feedback